Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts ...

Since 2014, prostate cancer cases have risen by 3% annually — and this year, former President Joe Biden is among the more ...

Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has already spread to his bones ...

Five- and eight-year trial data to be presented at ASCO demonstrate durable survival outcomes with Xtandi (enzalutamide) plus ...

Medically reviewed by Matthew Wosnitzer, MD Hormone treatment, also known as androgen deprivation therapy (ADT), is a ...

Astellas & Pfizer’s Xtandi shows long-term overall survival in metastatic hormone-sensitive prostate cancer: Tokyo Saturday, May 24, 2025, 13:00 Hrs [IST] Astellas Pharma Inc. a ...

According to Biden's office statement, his cancer has a Gleason score of 9 out of 10, meaning it's an aggressive form of ...

Joe Biden was diagnosed with an aggressive form of prostate cancer that has spread to his bones. He and his family are ...

Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to his bones, ...

"Historically, the likelihood of survival at five years for men with metastatic hormone-sensitive prostate cancer was low, but with advancements in initial treatment intensification like what we ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced longer-term follow-up results from an open-label extension of the Phase 3 ...

Former U.S. President Joe Biden's office announced that he has been diagnosed with "aggressive" prostate cancer, which has ...